Cargando…

Prognostic parameters on baseline and interim [(18)F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients

2-[(18)F]fluoro-2-deoxy-d-glucose PET/computed tomography ([(18)F]FDG-PET/CT) is a widely used imaging method in the management of diffuse large B-cell lymphomas (DLBCL). Our aim was to investigate the prognostic performance of different PET biomarkers in a multicenter setting. METHODS: We investiga...

Descripción completa

Detalles Bibliográficos
Autores principales: Czibor, Sándor, Carr, Robert, Redondo, Francisca, Auewarakul, Chirayu U., Cerci, Juliano J., Paez, Diana, Fanti, Stefano, Györke, Tamás
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994851/
https://www.ncbi.nlm.nih.gov/pubmed/36705233
http://dx.doi.org/10.1097/MNM.0000000000001664
_version_ 1784902704244457472
author Czibor, Sándor
Carr, Robert
Redondo, Francisca
Auewarakul, Chirayu U.
Cerci, Juliano J.
Paez, Diana
Fanti, Stefano
Györke, Tamás
author_facet Czibor, Sándor
Carr, Robert
Redondo, Francisca
Auewarakul, Chirayu U.
Cerci, Juliano J.
Paez, Diana
Fanti, Stefano
Györke, Tamás
author_sort Czibor, Sándor
collection PubMed
description 2-[(18)F]fluoro-2-deoxy-d-glucose PET/computed tomography ([(18)F]FDG-PET/CT) is a widely used imaging method in the management of diffuse large B-cell lymphomas (DLBCL). Our aim was to investigate the prognostic performance of different PET biomarkers in a multicenter setting. METHODS: We investigated baseline volumetric values [metabolic tumor volume (MTV) and total lesion glycolysis (TLG), also normalized for body weight] segmented with three different methods [>SUV4 (glob4); 41% isocontour (41pc), and a gradient-based lesion growing algorithm (grad)] and interim parameters [Deauville score, maximal standardized uptake value (ΔSUVmax), modified qPET, and ratio PET (rPET)] alongside clinical parameters (stage, revised International Prognostic Index), using 24-month progression-free survival as the clinical endpoint. Receiver operating characteristics analyses were performed to define optimal cutoff points for the continuous PET parameters. RESULTS: A total of 107 diffuse large B-cell lymphoma patients were included (54 women; mean age: 53.7 years). MTV and TLG calculations showed good correlation among glob4, 41pc, and grad methods; however, optimal cutoff points were markedly different. Significantly different PFS was observed between low- and high-risk groups according to baseline MTV, body weight-adjusted (bwa) MTV, TLG, bwaTLG, as well as interim parameters Deauville score, ΔSUVmax, mqPET, and rPET. Univariate Cox regression analyses showed hazard ratios (HRs) lowest for bwaMTVglob4 (HR = 2.3) and highest for rPET (HR = 9.09). In a multivariate Cox-regression model, rPET was shown to be an independent predictor of PFS (P = 0.041; HR = 9.15). Combined analysis showed that ΔSUVmax positive patients with high MTV formed a group with distinctly poor PFS (35.3%). CONCLUSION: Baseline MTV and TLG values and optimal cutoff points achieved with different segmentation methods varied markedly and showed a limited prognostic impact. Interim PET/CT parameters provided more accurate prognostic information with semiquantitative ‘Deauville-like’ parameters performing best in the present study.
format Online
Article
Text
id pubmed-9994851
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-99948512023-03-09 Prognostic parameters on baseline and interim [(18)F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients Czibor, Sándor Carr, Robert Redondo, Francisca Auewarakul, Chirayu U. Cerci, Juliano J. Paez, Diana Fanti, Stefano Györke, Tamás Nucl Med Commun Original Articles 2-[(18)F]fluoro-2-deoxy-d-glucose PET/computed tomography ([(18)F]FDG-PET/CT) is a widely used imaging method in the management of diffuse large B-cell lymphomas (DLBCL). Our aim was to investigate the prognostic performance of different PET biomarkers in a multicenter setting. METHODS: We investigated baseline volumetric values [metabolic tumor volume (MTV) and total lesion glycolysis (TLG), also normalized for body weight] segmented with three different methods [>SUV4 (glob4); 41% isocontour (41pc), and a gradient-based lesion growing algorithm (grad)] and interim parameters [Deauville score, maximal standardized uptake value (ΔSUVmax), modified qPET, and ratio PET (rPET)] alongside clinical parameters (stage, revised International Prognostic Index), using 24-month progression-free survival as the clinical endpoint. Receiver operating characteristics analyses were performed to define optimal cutoff points for the continuous PET parameters. RESULTS: A total of 107 diffuse large B-cell lymphoma patients were included (54 women; mean age: 53.7 years). MTV and TLG calculations showed good correlation among glob4, 41pc, and grad methods; however, optimal cutoff points were markedly different. Significantly different PFS was observed between low- and high-risk groups according to baseline MTV, body weight-adjusted (bwa) MTV, TLG, bwaTLG, as well as interim parameters Deauville score, ΔSUVmax, mqPET, and rPET. Univariate Cox regression analyses showed hazard ratios (HRs) lowest for bwaMTVglob4 (HR = 2.3) and highest for rPET (HR = 9.09). In a multivariate Cox-regression model, rPET was shown to be an independent predictor of PFS (P = 0.041; HR = 9.15). Combined analysis showed that ΔSUVmax positive patients with high MTV formed a group with distinctly poor PFS (35.3%). CONCLUSION: Baseline MTV and TLG values and optimal cutoff points achieved with different segmentation methods varied markedly and showed a limited prognostic impact. Interim PET/CT parameters provided more accurate prognostic information with semiquantitative ‘Deauville-like’ parameters performing best in the present study. Lippincott Williams & Wilkins 2023-04 2023-01-30 /pmc/articles/PMC9994851/ /pubmed/36705233 http://dx.doi.org/10.1097/MNM.0000000000001664 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Czibor, Sándor
Carr, Robert
Redondo, Francisca
Auewarakul, Chirayu U.
Cerci, Juliano J.
Paez, Diana
Fanti, Stefano
Györke, Tamás
Prognostic parameters on baseline and interim [(18)F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients
title Prognostic parameters on baseline and interim [(18)F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients
title_full Prognostic parameters on baseline and interim [(18)F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients
title_fullStr Prognostic parameters on baseline and interim [(18)F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients
title_full_unstemmed Prognostic parameters on baseline and interim [(18)F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients
title_short Prognostic parameters on baseline and interim [(18)F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients
title_sort prognostic parameters on baseline and interim [(18)f]fdg-pet/computed tomography in diffuse large b-cell lymphoma patients
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9994851/
https://www.ncbi.nlm.nih.gov/pubmed/36705233
http://dx.doi.org/10.1097/MNM.0000000000001664
work_keys_str_mv AT cziborsandor prognosticparametersonbaselineandinterim18ffdgpetcomputedtomographyindiffuselargebcelllymphomapatients
AT carrrobert prognosticparametersonbaselineandinterim18ffdgpetcomputedtomographyindiffuselargebcelllymphomapatients
AT redondofrancisca prognosticparametersonbaselineandinterim18ffdgpetcomputedtomographyindiffuselargebcelllymphomapatients
AT auewarakulchirayuu prognosticparametersonbaselineandinterim18ffdgpetcomputedtomographyindiffuselargebcelllymphomapatients
AT cercijulianoj prognosticparametersonbaselineandinterim18ffdgpetcomputedtomographyindiffuselargebcelllymphomapatients
AT paezdiana prognosticparametersonbaselineandinterim18ffdgpetcomputedtomographyindiffuselargebcelllymphomapatients
AT fantistefano prognosticparametersonbaselineandinterim18ffdgpetcomputedtomographyindiffuselargebcelllymphomapatients
AT gyorketamas prognosticparametersonbaselineandinterim18ffdgpetcomputedtomographyindiffuselargebcelllymphomapatients